43 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
the normal sleep-wake cycle. Narcolepsy is classified as two subtypes, NT1 and NT2. NT1 is caused by the profound loss of orexin-producing neurons … classified as partnerships for U.S. federal income tax purposes; persons who are subject to special tax accounting under Section 451(b) of the Code
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
that affects the brain’s ability to regulate the normal sleep-wake cycle. Narcolepsy is classified as two subtypes, NT1 and NT2. NT1 is caused … or currencies; tax-exempt entities or government organizations; S corporations, partnerships, or other entities or arrangements classified as partnerships
S-3ASR
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
is classified, stockholders may effect such removal only for cause, or (ii) in the case of a corporation having cumulative voting, if less than
424B5
piibf6vvd
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
ytcdo3l w5toy
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
gat1y1ej6fidcca5
23 Apr 24
Prospectus supplement for primary offering
5:16pm
S-3
7431r18n21nkxb86kv3g
1 Jul 22
Shelf registration
4:06pm
10-K
EX-10.35
dt8b2vmcpa671tlvw5
30 Mar 22
Annual report
12:00am
10-K
0xm3oarh3h
30 Mar 22
Annual report
12:00am